Top-Rated Stocks NASDAQ:RCM R1 RCM - RCM Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding R1 RCM Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $14.56 +0.26 (+1.82%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$14.23▼$14.6550-Day Range$12.42▼$14.8952-Week Range$6.71▼$27.86Volume2.11 million shsAverage Volume2.69 million shsMarket Capitalization$6.07 billionP/E RatioN/ADividend YieldN/APrice Target$16.85 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial MediaSustainability R1 RCM MarketRank™ ForecastAnalyst RatingModerate Buy2.83 Rating ScoreUpside/Downside15.7% Upside$16.85 Price TargetShort InterestBearish9.39% of Float Sold ShortDividend StrengthN/ASustainability-1.33Upright™ Environmental ScoreNews Sentiment0.79Based on 5 Articles This WeekInsider TradingAcquiring Shares$999,714 Bought Last QuarterProj. Earnings Growth138.89%From $0.18 to $0.43 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.63 out of 5 starsBusiness Services Sector70th out of 328 stocksManagement Services Industry1st out of 7 stocks 3.4 Analyst's Opinion Consensus RatingR1 RCM has received a consensus rating of Buy. The company's average rating score is 2.83, and is based on 10 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $16.85, R1 RCM has a forecasted upside of 15.7% from its current price of $14.56.Amount of Analyst CoverageR1 RCM has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 1.0 Short Interest Percentage of Shares Shorted9.39% of the float of R1 RCM has been sold short.Short Interest Ratio / Days to CoverR1 RCM has a short interest ratio ("days to cover") of 6.7.Change versus previous monthShort interest in R1 RCM has recently increased by 5.09%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldR1 RCM does not currently pay a dividend.Dividend GrowthR1 RCM does not have a long track record of dividend growth. Previous Next 3.6 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreR1 RCM has received a 45.11% net impact score from Upright. R1 Rcm seems to create the most significant positive value in categories "Jobs", "Taxes", and "Physical diseases". The positive contribution in the "Physical diseases" impact category is mostly driven by its "Documentation software for clinicians", "Personal health record software", and "Hospital cost management software" products. See details.Environmental SustainabilityThe Environmental Impact score for R1 RCM is -1.33. Previous Next 2.7 News and Social Media Coverage News SentimentR1 RCM has a news sentiment score of 0.79. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.54 average news sentiment score of Business Services companies.News Coverage This WeekMarketBeat has tracked 5 news articles for R1 RCM this week, compared to 3 articles on an average week.MarketBeat FollowsOnly 1 people have added R1 RCM to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 5.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, R1 RCM insiders have bought more of their company's stock than they have sold. Specifically, they have bought $999,714.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders59.40% of the stock of R1 RCM is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions97.09% of the stock of R1 RCM is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for R1 RCM are expected to grow by 138.89% in the coming year, from $0.18 to $0.43 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of R1 RCM is -104.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of R1 RCM is -104.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioR1 RCM has a PEG Ratio of 8.24. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioR1 RCM has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About R1 RCM (NASDAQ:RCM) StockR1 RCM, Inc. engages in the provision of revenue cycle management to healthcare providers. It offers end-to-end, modular revenue cycle, and physician advisory services. The company was founded by Mary Ann Tolan and J. Michael Cline in July 2003 and is headquartered in Murray, UT.Read More Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Stock News HeadlinesMarch 27, 2023 | marketwatch.comHealthcare Revenue Cycle Management Software Market by Product Type and Consumers-2031March 24, 2023 | marketwatch.comHealthcare Revenue Cycle Management Software Market Trends, Industry Demand and Scope, Top Players Analysis, Forecast 2023 - 2031March 27, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 21, 2023 | uk.finance.yahoo.comRevenue Cycle Management (RCM) Global Market Report 2023March 20, 2023 | marketwatch.comHealthcare Revenue Cycle Management Software Market Latest Innovations and Future Expansion 2023-2029March 17, 2023 | marketwatch.comHealthcare Revenue Cycle Management Software Market Size Report till 2029March 17, 2023 | finance.yahoo.comThose who invested in R1 RCM (NASDAQ:RCM) five years ago are up 84%March 17, 2023 | finance.yahoo.comQ4 2022 Cymabay Therapeutics Inc Earnings CallMarch 27, 2023 | Behind the Markets (Ad)Buy THIS stock before Taiwan is attacked... If the United States goes to war with another nuclear armed superpower, this could have a devastating impact on your retirement portfolio. Now, even Taiwan's own foreign minister is saying that China is on the cusp of a full scale invasion. But the good news is, if China invades Taiwan, there is a way to protect yourself.March 15, 2023 | marketwatch.comHealthcare Business Process Outsourcing Market Application, Product, Sales and Forecast 2023-2028March 9, 2023 | marketwatch.comThe Healthcare RCM Outsourcing study investigates the market's expansion over the previous few years and into the foreseeable future.March 8, 2023 | barrons.comS&P 500 Futures Rise in Premarket Trading; CrowdStrike Holdings, R1 RCM LeadMarch 1, 2023 | finance.yahoo.comR1 RCM Issues 2022 Environmental, Social, and Governance ReportFebruary 28, 2023 | finance.yahoo.comR1 RCM (RCM) Faced Multiple Challenges in Q4February 27, 2023 | marketwatch.comRevenue Cycle Management Market (New Updated Report) Size and Share Expanding worldwide by 2023-2029 | 60 Pages ReportFebruary 23, 2023 | marketwatch.comA Closer Look at the Revenue Cycle Management (RCM) System Market (2023 to 2029)-Opportunities and ChallengesFebruary 20, 2023 | finance.yahoo.comRevenue Cycle Management Software Global Market Report 2023February 18, 2023 | seekingalpha.comR1 RCM, Inc. (RCM) Q4 2022 Earnings Call TranscriptFebruary 18, 2023 | finance.yahoo.comR1 RCM Full Year 2022 Earnings: EPS Misses ExpectationsFebruary 17, 2023 | markets.businessinsider.comAnalysts Are Neutral on These Services Stocks: R1 RCM (RCM), Texas Roadhouse (TXRH)February 16, 2023 | marketwatch.comR1 RCM Shares Rise 7% After 4Q Revenue Beats ExpectationsFebruary 16, 2023 | finance.yahoo.comWhy R1 RCM Stock Is Surging TodayFebruary 16, 2023 | msn.comR1 RCM GAAP EPS of -$0.09 misses by $0.04, revenue of $532.8M beats by $13.52MFebruary 16, 2023 | finance.yahoo.comR1 RCM Reports Fourth Quarter and Full Year 2022 ResultsFebruary 16, 2023 | finance.yahoo.comR1 RCM Inc. (RCM) Reports Q4 Loss, Tops Revenue EstimatesFebruary 15, 2023 | msn.comR1 RCM Earnings PreviewFebruary 10, 2023 | marketwatch.com2023, Current Status and Future Prospects Of Revenue Cycle Management (RCM) System MarketSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive RCM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for R1 RCM and its competitors with MarketBeat's FREE daily newsletter. Email Address RCM Company Calendar Last Earnings2/16/2023Today3/27/2023Next Earnings (Estimated)5/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Management services Sub-IndustryHealth Care Services SectorBusiness Services Current SymbolNASDAQ:RCM Previous SymbolNYSE:RCM CUSIP00438V10 CIK1472595 Webwww.r1rcm.com Phone(312) 324-7820Fax302-655-5049Employees22,000Year Founded2003Price Target and Rating Average Stock Price Forecast$16.85 High Stock Price Forecast$25.00 Low Stock Price Forecast$10.00 Forecasted Upside/Downside+16.7%Consensus RatingModerate Buy Rating Score (0-4)2.83 Research Coverage12 Analysts Profitability EPS (Most Recent Fiscal Year)($0.14) Trailing P/E RatioN/A Forward P/E Ratio80.17 P/E Growth8.24Net Income$-57,600,000.00 Net Margins-3.19% Pretax Margin-3.38% Return on Equity0.05% Return on Assets0.03% Debt Debt-to-Equity Ratio0.64 Current Ratio1.61 Quick RatioN/A Sales & Book Value Annual Sales$1.81 billion Price / Sales3.33 Cash Flow$0.29 per share Price / Cash Flow50.47 Book Value$6.53 per share Price / Book2.21Miscellaneous Outstanding Shares416,660,000Free Float169,165,000Market Cap$6.01 billion OptionableNot Optionable Beta0.82 Social Links Key ExecutivesLee RivasChief Executive Officer & DirectorJohn SparbyPresidentKristina BourkeExecutive Vice President-OperationsJennifer WilliamsChief Financial Officer & EVPHarvey EwingChief Information Officer & Executive VPKey CompetitorsShift4 PaymentsNYSE:FOUREvoqua Water TechnologiesNYSE:AQUANuveiNASDAQ:NVEIDuolingoNYSE:DUOLRitchie Bros. AuctioneersNYSE:RBAView All CompetitorsInsiders & InstitutionsNeo Ivy Capital ManagementBought 32,946 shares on 3/27/2023Ownership: 0.008%MetLife Investment Management LLCSold 1,655 shares on 3/23/2023Ownership: 0.039%Voya Investment Management LLCBought 22,246 shares on 2/28/2023Ownership: 0.244%P2 Capital Partners LLCBought 563,269 shares on 2/23/2023Ownership: 0.135%Teachers Retirement System of The State of KentuckySold 141,922 shares on 2/22/2023Ownership: 0.005%View All Insider TransactionsView All Institutional Transactions RCM Stock - Frequently Asked Questions Should I buy or sell R1 RCM stock right now? 12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for R1 RCM in the last year. There are currently 2 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" RCM shares. View RCM analyst ratings or view top-rated stocks. What is R1 RCM's stock price forecast for 2023? 12 brokerages have issued 12-month price objectives for R1 RCM's shares. Their RCM share price forecasts range from $10.00 to $25.00. On average, they expect the company's stock price to reach $16.85 in the next twelve months. This suggests a possible upside of 16.3% from the stock's current price. View analysts price targets for RCM or view top-rated stocks among Wall Street analysts. How have RCM shares performed in 2023? R1 RCM's stock was trading at $10.95 at the beginning of 2023. Since then, RCM shares have increased by 32.2% and is now trading at $14.48. View the best growth stocks for 2023 here. When is R1 RCM's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023. View our RCM earnings forecast. How were R1 RCM's earnings last quarter? R1 RCM Inc. (NASDAQ:RCM) issued its quarterly earnings data on Thursday, February, 16th. The healthcare provider reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.06. The healthcare provider earned $532.80 million during the quarter, compared to the consensus estimate of $519.28 million. R1 RCM had a positive trailing twelve-month return on equity of 0.05% and a negative net margin of 3.19%. The business's revenue for the quarter was up 33.6% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.11 earnings per share. What ETFs hold R1 RCM's stock? ETFs with the largest weight of R1 RCM (NASDAQ:RCM) stock in their portfolio include Global X Telemedicine & Digital Health ETF (EDOC), Fidelity Digital Health ETF (FDHT), SPDR S&P Health Care Services ETF (XHS), Thrivent Small-Mid Cap ESG ETF (TSME), Pacer Lunt MidCap Multi-Factor Alternator ETF (PAMC), ERShares NextGen Entrepreneurs ETF (ERSX), iShares U.S. Healthcare Providers ETF (IHF) and Invesco NASDAQ Next Gen 100 ETF (QQQJ). What guidance has R1 RCM issued on next quarter's earnings? R1 RCM issued an update on its FY 2023 earnings guidance on Friday, February, 24th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.28 billion-$2.33 billion, compared to the consensus revenue estimate of $2.30 billion. What is Joseph Flanagan's approval rating as R1 RCM's CEO? 253 employees have rated R1 RCM Chief Executive Officer Joseph Flanagan on Glassdoor.com. Joseph Flanagan has an approval rating of 70% among the company's employees. What other stocks do shareholders of R1 RCM own? Based on aggregate information from My MarketBeat watchlists, some companies that other R1 RCM investors own include NVIDIA (NVDA), JD.com (JD), Baozun (BZUN), Inseego (INSG), BioXcel Therapeutics (BTAI), Marvell Technology (MRVL), Akoustis Technologies (AKTS), Alibaba Group (BABA), Bilibili (BILI) and Model N (MODN). What is R1 RCM's stock symbol? R1 RCM trades on the NASDAQ under the ticker symbol "RCM." Who are R1 RCM's major shareholders? R1 RCM's stock is owned by a number of institutional and retail investors. Top institutional investors include New Mountain Capital L.L.C. (22.67%), Point72 Asset Management L.P. (2.60%), Sachem Head Capital Management LP (1.63%), American Century Companies Inc. (1.25%), Sunriver Management LLC (1.11%) and Morgan Stanley (1.06%). Insiders that own company stock include Achi Series Lllp Tcp-Asc, Alex Mandl, Gary Steven Long, John M Sparby, Joseph Gerard Flanagan, Lee Rivas, Michael C Feiner and Richard B Jr Evans. View institutional ownership trends. How do I buy shares of R1 RCM? Shares of RCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is R1 RCM's stock price today? One share of RCM stock can currently be purchased for approximately $14.48. How much money does R1 RCM make? R1 RCM (NASDAQ:RCM) has a market capitalization of $6.03 billion and generates $1.81 billion in revenue each year. The healthcare provider earns $-57,600,000.00 in net income (profit) each year or ($0.14) on an earnings per share basis. How many employees does R1 RCM have? The company employs 22,000 workers across the globe. Does R1 RCM have any subsidiaries? The following companies are subsidiares of R1 RCM: Accretive Health Mauritius Inc., Cerner RevWorks, Clearsight Intermediate Holdings Inc., Cloudmed, Flare Capital Partners Investment Company, Intermedix, Intermedix ARM LLC, Intermedix Corporation, Intermedix Holdings Inc., Intermedix Lietuva UAB, Intermedix Midco Inc., Intermedix Office Based LLC, Intermedix Staffing Inc., Medical Consultants Inc., Practice Support Resources LLC, Project Links Parent Inc., Project Roadrunner Merger Sub Inc., Project Roadrunner Parent Inc., R1 RCM Global Private Limited, R1 RCM India Private Limited, Rover16 Inc., SCHEDULING.COM INC., SCI Solutions, Tonic Health LLC, VisitPay, cGate Health Inc., and iVinci Partners LLC.Read More How can I contact R1 RCM? R1 RCM's mailing address is 401 NORTH MICHIGAN AVENUE SUITE 2700, CHICAGO IL, 60611. The official website for the company is www.r1rcm.com. The healthcare provider can be reached via phone at (312) 324-7820, via email at arahim@r1rcm.com, or via fax at 302-655-5049. This page (NASDAQ:RCM) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.